In the Western blot analysis and ELISA detection validation results, the expression of SLURP1 in the urine of patients with PCa group was found to be significantly increased compared to both the normal control group and the BPH group, with statistical significance (P<0.05). Here, SLURP1 is linked to benign prostatic hyperplasia.